Showing results (141-150 of 225) with videos related to

Sort By:
Pageof 23
Current Urology|October 12, 2019
Positive Association between Preoperative Total Testosterone and Lymph Node Invasion in Intermediate Risk Prostate CancerAntonio B Porcaro, Alessandro Tafuri, Marco Sebben, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 8, 2025
Management of Small Renal Masses: Literature and Guidelines ReviewAntonio Silvestri, Filippo Gavi, Maria Chiara Sighinolfi, et al.
Current Urology Reports|May 26, 2025
Multiomics in Renal Cell Carcinoma: Current Landscape and Future Directions for Precision MedicineFilippo Gavi, Maria Chiara Sighinolfi, Giuseppe Pallotta, et al.
British Journal of Clinical Pharmacology|March 19, 2015
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecanFelicia Stefania Falvella, Stefania Cheli, Antonia Martinetti, et al.
Clinical Genitourinary Cancer|November 7, 2018
Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 StudyCristina Masini, Maria Giuseppa Vitale, Marco Maruzzo, et al.
Medicina (Kaunas, Lithuania)|December 23, 2023
Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?Pierluigi Russo, Filippo Marino, Francesco Rossi, et al.
Targeted Oncology|November 6, 2015
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal CancerFilippo Pietrantonio, Filippo de Braud, Massimo Milione, et al.
Expert Review of Cardiovascular Therapy|December 13, 2019
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studiesMatteo Santoni, Alessandro Conti, Francesco Massari, et al.
Oncotarget|October 15, 2016
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approachMichelangelo Fiorentino, Elisa Gruppioni, Francesco Massari, et al.
Cancers|February 10, 2024
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical CystectomyPierluigi Russo, Giuseppe Palermo, Roberto Iacovelli, et al.
Pageof 23